Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03228212 · ClinicalTrials.gov registry record · NA
Evaluation of Approved and Investigational Contact Lenses
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
NCT03228212 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 133 participants.
The verdict
NCT03228212, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
Study Summary
This study is a randomized, 5-visit, partial subject masked, 2x3 bilateral crossover, dispensing clinical trial. During the study, each test article will be worn in a daily wear modality for at least 6 hours per day and 5 days per week for approximately 2 weeks each. The subject will wear either the Test or Control article twice and the other study article once. The primary objective of this study is to demonstrate that the Test lens works as well, if not better compared to the Control lens with respect to CLUE (Contact Lens User Experience) comfort, Slit Lamp findings, and Distance Monocular logMAR Visual Acuity. This study will also aim to show acceptable lens fit for subjects wearing the Test lens.
Interventions
- DEVICE CONTROL
- DEVICE TEST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2017-07-14 |
| Est. Completion | 2017-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03228212
The ClinicalTrials.gov registry entry for NCT03228212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CONTROL is the first listed.
NCT03228212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03228212 about?
NCT03228212 is a clinical study titled "Evaluation of Approved and Investigational Contact Lenses". This study is a randomized, 5-visit, partial subject masked, 2x3 bilateral crossover, dispensing clinical trial. During the study, each test article will be worn in a daily wear modality for at least 6 hours per day and 5 days per week for approximately 2 weeks each. The subject will wear either the...
What is the current status of trial NCT03228212?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2017-07-14. Estimated completion is 2017-09-18.
What interventions are being tested in trial NCT03228212?
The interventions under investigation include: CONTROL (DEVICE), TEST (DEVICE).
Who is sponsoring clinical trial NCT03228212?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.